Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Trisomy 21
ADR ID BADD_A04395
ADR Hierarchy
02      Cardiac disorders
02.08      Congenital cardiac disorders
02.08.02      Congenital cardiovascular disorders NEC
02.08.02.003      Trisomy 21
03      Congenital, familial and genetic disorders
03.12      Chromosomal abnormalities and abnormal gene carriers
03.12.01      Autosomal chromosomal abnormalities
03.12.01.003      Trisomy 21
17      Nervous system disorders
17.03      Mental impairment disorders
17.03.07      Intellectual disabilities
17.03.07.005      Trisomy 21
19      Psychiatric disorders
19.21      Cognitive and attention disorders and disturbances
19.21.06      Intellectual disabilities
19.21.06.005      Trisomy 21
Description A chromosome disorder associated either with an extra chromosome 21 or an effective trisomy for chromosome 21. Clinical manifestations include hypotonia, short stature, brachycephaly, upslanting palpebral fissures, epicanthus, Brushfield spots on the iris, protruding tongue, small ears, short, broad hands, fifth finger clinodactyly, Simian crease, and moderate to severe INTELLECTUAL DISABILITY. Cardiac and gastrointestinal malformations, a marked increase in the incidence of LEUKEMIA, and the early onset of ALZHEIMER DISEASE are also associated with this condition. Pathologic features include the development of NEUROFIBRILLARY TANGLES in neurons and the deposition of AMYLOID BETA-PROTEIN, similar to the pathology of ALZHEIMER DISEASE. (Menkes, Textbook of Child Neurology, 5th ed, p213) [MeSH]
MedDRA Code 10044688
MeSH ID D004314; D004314; D004314
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Down's syndrome | Mongolism | Syndrome Down's | Trisomy 21 | Down Syndrome | Syndrome, Down | 47,XY,+21 | Trisomy G | 47,XX,+21 | Down's Syndrome | Downs Syndrome | Syndrome, Down's | Trisomy 21, Mitotic Nondisjunction | Down Syndrome, Partial Trisomy 21 | Partial Trisomy 21 Down Syndrome | Trisomy 21, Meiotic Nondisjunction
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00285Bosentan0.000175%
BADD_D00356Carbamazepine0.004210%
BADD_D00419Cetrorelix--
BADD_D00420Cetrorelix acetate--
BADD_D00421Cetrorelix trifluoroacetate--
BADD_D00475Citalopram0.000022%
BADD_D00497Clomiphene--
BADD_D00498Clomiphene citrate--
BADD_D00586Darunavir0.001622%
BADD_D00653Diclofenac0.000178%
BADD_D00661Didanosine0.041492%
BADD_D00932Fluoxetine0.000272%
BADD_D01075Homatropine--
BADD_D01107Hydroxyprogesterone caproate-
BADD_D01257Letrozole0.001230%
BADD_D01265Levetiracetam0.002856%
BADD_D01281Levonorgestrel0.001088%
BADD_D01366Medroxyprogesterone acetate--
BADD_D01380Menotropins--
BADD_D01401Metformin0.000014%
BADD_D01617Ondansetron0.000200%
BADD_D01637Oxcarbazepine0.001247%
BADD_D01679Paroxetine0.000280%
BADD_D01888Quetiapine0.000382%
BADD_D02010Sertraline0.000181%
BADD_D02155Tenofovir disoproxil0.008886%
BADD_D02329Valproic acid0.000664%
BADD_D02346Venlafaxine0.000149%
BADD_D02438Enoxaparin0.001049%
The 1th Page    1    Total 1 Pages